Anthem Biosciences Limited (BOM:544449)
908.60
-33.80 (-3.59%)
At close: Sep 16, 2026
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 531.01 billion as of September 16, 2026. Its market cap has increased by 13.44% in one year.
Market Cap
531.01B
Enterprise Value
522.16B
Revenue
20.07B
Ranking
n/a
PE Ratio
92.20
Stock Price
908.60
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 531.01B, an increase of 29.46%. That is a compound annual growth rate of 25.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 531.01B | 45.13% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Schaeffler India | 617.20B |
| APL Apollo Tubes | 597.80B |
| Abbott India | 543.69B |
| Linde India | 530.75B |
| Berger Paints India | 521.44B |
| Hindustan Copper | 497.39B |
| Colgate-Palmolive (India) | 488.92B |
| UPL Limited | 484.43B |